[go: up one dir, main page]

WO2009004152A3 - Utilisation d'une composition d'oligomères d'acide galacturonique en tant qu'agent pour inhiber la dégradation du collagène - Google Patents

Utilisation d'une composition d'oligomères d'acide galacturonique en tant qu'agent pour inhiber la dégradation du collagène Download PDF

Info

Publication number
WO2009004152A3
WO2009004152A3 PCT/FR2008/000716 FR2008000716W WO2009004152A3 WO 2009004152 A3 WO2009004152 A3 WO 2009004152A3 FR 2008000716 W FR2008000716 W FR 2008000716W WO 2009004152 A3 WO2009004152 A3 WO 2009004152A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
agent
galacturonic acid
oligomers
collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2008/000716
Other languages
English (en)
Other versions
WO2009004152A2 (fr
Inventor
Said Kamel
Romuald Mentaverri
Jean Marc Lion
Michel Brazier
Josiane Courtois-Sambourg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Picardie Jules Verne
Original Assignee
Universite de Picardie Jules Verne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Picardie Jules Verne filed Critical Universite de Picardie Jules Verne
Publication of WO2009004152A2 publication Critical patent/WO2009004152A2/fr
Publication of WO2009004152A3 publication Critical patent/WO2009004152A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation d'une composition d'oligomères d'acide galacturonique présentant un degré de polymérisation compris sensiblement entre 5 et 25 en tant qu'agent pour inhiber la dégradation du collagène. L'invention concerne également l'utilisation d'une telle composition pour la préparation d'un médicament contre l'ostéoporose, le cancer, l'angiogénèse et la prolifération des métastases.
PCT/FR2008/000716 2007-05-25 2008-05-26 Utilisation d'une composition d'oligomères d'acide galacturonique en tant qu'agent pour inhiber la dégradation du collagène Ceased WO2009004152A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0703707A FR2916353B1 (fr) 2007-05-25 2007-05-25 Composition pharmaceutique destinee a preserver le collagene
FR0703707 2007-05-25

Publications (2)

Publication Number Publication Date
WO2009004152A2 WO2009004152A2 (fr) 2009-01-08
WO2009004152A3 true WO2009004152A3 (fr) 2009-08-06

Family

ID=38859092

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/000716 Ceased WO2009004152A2 (fr) 2007-05-25 2008-05-26 Utilisation d'une composition d'oligomères d'acide galacturonique en tant qu'agent pour inhiber la dégradation du collagène

Country Status (2)

Country Link
FR (1) FR2916353B1 (fr)
WO (1) WO2009004152A2 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE672883A (fr) * 1964-12-31 1966-03-16
US5952308A (en) * 1991-07-29 1999-09-14 Pola Chemical Industries Inc. Mineral absorption promoting agent
US20030100535A1 (en) * 2001-11-21 2003-05-29 Yan Chang Method for controlling angiogenesis in animals
WO2004098543A2 (fr) * 2003-05-06 2004-11-18 Laboratoires De Biologie Vegetale Yves Rocher Utilisation d’oligosaccharides de type oligogalacturonide dans des compositions cosmetiques, alimentaires ou dermatologiques pour stimuler la differenciation de cellules epidermiques
WO2005095463A1 (fr) * 2004-03-26 2005-10-13 Glycogenesys, Inc. Pectines modifiees, compositions associees et procedes correspondants

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE672883A (fr) * 1964-12-31 1966-03-16
US5952308A (en) * 1991-07-29 1999-09-14 Pola Chemical Industries Inc. Mineral absorption promoting agent
US20030100535A1 (en) * 2001-11-21 2003-05-29 Yan Chang Method for controlling angiogenesis in animals
WO2004098543A2 (fr) * 2003-05-06 2004-11-18 Laboratoires De Biologie Vegetale Yves Rocher Utilisation d’oligosaccharides de type oligogalacturonide dans des compositions cosmetiques, alimentaires ou dermatologiques pour stimuler la differenciation de cellules epidermiques
WO2005095463A1 (fr) * 2004-03-26 2005-10-13 Glycogenesys, Inc. Pectines modifiees, compositions associees et procedes correspondants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STRICKLAND F M ET AL: "PRESERVATION OF THE DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO ALLOANTIGEN BY XYLOGLUCANS OR OLIGOGALACTURONIDE DOES NOT CORRELATE WITH THE CAPACITY TO REJECT ULTRAVIOLET-INDUCED SKIN TUMORS IN MICE", JOURNAL OF INVESTIGATIVE DERMATOLOGY, NEW YORK, NY, US, vol. 116, no. 1, January 2001 (2001-01-01), pages 62 - 68, XP001180731, ISSN: 0022-202X *

Also Published As

Publication number Publication date
WO2009004152A2 (fr) 2009-01-08
FR2916353A1 (fr) 2008-11-28
FR2916353B1 (fr) 2010-09-24

Similar Documents

Publication Publication Date Title
WO2011042613A3 (fr) Composition antimicrobienne
WO2008045534A3 (fr) Nouveaux dérivés de curcumine et de tétrahydrocurcumine
WO2008097640A3 (fr) Composés à base de triazole modulant l'activité de hsp90
WO2011077043A3 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
WO2008049020A3 (fr) Gel de diclofénac
WO2007081991A3 (fr) Nouveaux materiaux conjugues dotes d’unites proquinoidales
WO2008100601A3 (fr) Compositions d'administration d'agent bénéfique
WO2009043353A3 (fr) Oligonucléotides micromir
WO2013116804A3 (fr) Biomatériaux polymères dérivés de monomères phénoliques et leurs utilisations à des fins médicales
GB0916338D0 (en) Branched addition copolymers in curing systems
WO2011062965A8 (fr) Monomères de ciblage et polymère ayant des blocs de ciblage
WO2010011296A3 (fr) Inhibiteurs de désacétylase et leurs utilisations
WO2008089034A3 (fr) Inhibiteurs de cytokine
WO2011101621A3 (fr) Compositions de transfert de chaleur
WO2009149339A3 (fr) Peptides activateurs de p53
WO2012042224A8 (fr) Composition pharmaceutique
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
WO2010033977A3 (fr) Composes multiheteroaryles servant d'inhibiteurs de la h-pgds, ainsi que leur utilisation dans le traitement des maladies induites par la prostaglandine d2
EP2157113A3 (fr) Éthylènediamines aminopropylés d'alkylat et utilisations associées
WO2012003501A3 (fr) Compositions, synthèse et procédés d'utilisation de dérivés de cycloalkylméthylamine
WO2010026590A3 (fr) Nouvelles compositions adhésives biodégradables
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2009114461A3 (fr) Formes pharmaceutiques d'angiotensine (1-7) et leur utilisation
ZA200707973B (en) Low amounts of high molecular weight polymer for enhancing viscosity of aqueous/aqueous biphasic liquids
WO2008036377A3 (fr) Nouveaux sels à base de triclosan

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08805607

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08805607

Country of ref document: EP

Kind code of ref document: A2